Video interview with Dr Isabelle Schiffer on senolytic safety

Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic.

The Forever Healthy Foundation published its latest risk-benefit analysis, which explores the combined use of cancer drug dasatinib with quercetin, a polyphenol common in plants, as a senolytic therapy.

After screening more than 3300 scientific papers and analysing more than 150 clinical and pre-clinical studies, Forever Healthy concludes that the use of DQ as a senolytic therapy should be avoided – “until there are more published results showing benefits in humans, a clearer picture of the senolytic-use specific risk profile, and a consensus on treatment protocols.”

Learn more in this exclusive video interview with Dr Isabelle Schiffer, the scientific spokesperson for Forever Healthy:

Image courtesy of the Forever Healthy Foundation


Danny Sullivan
Contributing Editor Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.

Latest articles

VC enters Longevity market with K4Connect deal

We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity. Longevity agetech company K4Connect has announced...

Challenging the one drug/one disease model

A new paper supports the targeting of aging processes, rather than just one disease, to improve Longevity outcomes. Multimorbidity is a challenge for Longevity; defined...

Robotics and AI combine for new therapeutics discovery

Insilico Medicine and Arctoris announce robotics/AI partnership to focus on COVID-19 inhibitors that could have wide-reaching benefits for Longevity. Two companies have joined forces in...

The results are in: sharing our Longevity investment survey

There is rapidly-increasing activity in both the research and the investment communities that focus on Longevity; this survey gets into the details. The global Longevity...